Scott Power

Senior Analyst - Healthcare, Life Science & Technology @ CGS-CIMB
Scott has spent over 20 years investing in and researching emerging companies. Firstly in his role in the venture capital industry with QIDC and more recently with Morgans. Australia has always been seen as a country which produces world class technology, particularly in the life science sector. Companies like Cochlear, CSL and Resmed have established themselves as market leaders and a number of up and coming companies across healthcare, life science and technology sector will follow these companies, potentially generating significant profits. Scott has wide network of contacts across these sectors which help with identification of key trends and developments.
Articles by this analyst can only be viewed by CGS-CIMB clients.
Start reading our world-class research today — absolutely free.
- 1 Macro Analysis/Global The countries most vulnerable to tight global financial conditions – in 2 charts
- 2 Global Themes/Global What investors are thinking: Takeaways from our UK roadshow
- 3 Sovereign Analysis/Sri Lanka Sri Lanka's restructuring is off to a rocky start
- 4 Macro Analysis/Nigeria Nigeria's oil recovery target sounds too good to be true
- 5 Macro Analysis/United States of America US economy: IMF warns over inflation risks but economy to avoid recession